Target intelligence / Profile preview

Immunoglobulin kappa variable 2D-24 (IGKV2D-24)

Target
IGKV2D-24
Molecular classification
Immunoglobulin variable region, Other (germline gene segment, not a receptor or enzyme in itself)
01

Overview

Immunoglobulin kappa variable 2D-24 (IGKV2D-24) is a gene segment found in the distal cluster of the immunoglobulin kappa (IGK) light chain locus at chromosome 2p11.2[3][4]. It encodes the variable (V) region of the light chain of immunoglobulins. Most evidence indicates IGKV2D-24 is a probable non-functional open reading frame (ORF), meaning it generally cannot participate in the synthesis of a productive immunoglobulin light chain due to mutations affecting recombination, splicing, or conserved amino acid sequences[1][4][5]. Immunoglobulin V region genes are critical for the generation of antibody diversity via somatic recombination (V-J for kappa chain), enabling B cell receptors and secreted antibodies to recognize a vast array of antigens[3][4][5]. The IGKV2D-24 gene can be rearranged during lymphocyte development, but its products are typically not expressed at the protein level due to nonfunctionality. The overall kappa locus contains both functional V genes and non-functional ORFs and pseudogenes[4][3]. IGKV2D-24 does not act as a classical receptor, enzyme, or target in pharmacology.

Other names
Probable non-functional immunoglobulin kappa variable 2D-24IGKV2D24A7KVD24_HUMAN
02

Biological functions

Immune response (as a component of antibody gene rearrangement)Antigen recognition (as part of the variable domain of antibodies, though for IGKV2D-24, function is probably lost)
03

Disease associations

Other (possible contribution to immune repertoire variability; not directly implicated in diseases as an individual locus)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 2D-24 (IGKV2D-24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 2D-24 (IGKV2D-24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call